95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Analyze analyst forecasts for the company and compare them with competitors.
1.65B
The estimated revenue has increased from the previous period.
1.15B
The estimated EBITDA has increased from the previous period.
1.90
The estimated EPS has increased from the previous period.
807.02M
The estimated net income has increased from the previous period.
758.24M
The estimated EBIT has increased from the previous period.
89.28M
The estimated SG&A expenses have increased from the previous period.
Analyze DCF forecasts for the company and compare them with competitors.
861.33M
No previous data to compare.
No Data
No DCF data available for this metric in the selected year.
393.64M
No previous data to compare.
45.70%
No previous data to compare.
128.89M
No previous data to compare.
14.96%
No previous data to compare.
264.74M
No previous data to compare.
103.99M
No previous data to compare.
12.07%
No previous data to compare.
4.35M
No previous data to compare.
0.51%
No previous data to compare.
41.50M
No previous data to compare.
4.82%
No previous data to compare.
11.79M
No previous data to compare.
1.37%
No previous data to compare.
-3.21M
No previous data to compare.
-0.37%
No previous data to compare.
7.76%
No previous data to compare.
7.74%
No previous data to compare.
88.46%
No previous data to compare.
0.71
No previous data to compare.
453.46M
No previous data to compare.
6.23M
No previous data to compare.
25.95B
No previous data to compare.
25.95B
No previous data to compare.
0.02%
No previous data to compare.
99.98%
No previous data to compare.
144.06M
No previous data to compare.
371.54M
No previous data to compare.
2.00%
No previous data to compare.
10.89B
No previous data to compare.
9.71B
No previous data to compare.
-540.30M
No previous data to compare.
10.25B
No previous data to compare.
22.61
No previous data to compare.
View analysts' price targets and recommendations, and compare them with competitors.
$100.50
Analysts expect the stock price to increase by 3.93%.
Buy
Positive consensus among analysts.
